Search research articles
Contact Us
Filters
Showing results (51-60 of 189) with videos related to
Page
of 19
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 18, 2012
The significance of defining preclinical or prodromal Parkinson's disease
C Warren Olanow, José A Obeso
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 22, 2011
Movement disorders 2011--the state of the journal
C Warren Olanow, Jose A Obeso
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 20, 2014
Impact factor for 2013
C Warren Olanow, Jose A Obeso
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 24, 2021
Parkinson's Disease Modification Through Abl Kinase Inhibition: An Opportunity
Milton H Werner, C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 11, 2008
Treatment of levodopa-induced motor complications
Fabrizio Stocchi, Michele Tagliati, C Warren Olanow
Annals of Neurology
|
July 25, 2006
Proteasome inhibitor-induced model of Parkinson's disease
Kevin St P McNaught, C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 11, 2014
Initiating levodopa therapy for Parkinson's disease
C Warren Olanow, Karl Kieburtz, Fabrizio Stocchi
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 9, 2018
Huntington's disease: Current and future therapeutic prospects
Karl Kieburtz, Ralf Reilmann, C Warren Olanow
Annals of Neurology
|
April 1, 2003
Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease
Kevin St P McNaught, C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 15, 2006
Ubiquitin-proteasome system and Parkinson's disease
C Warren Olanow, Kevin St P McNaught
Page
of 19
Search research articles
Search
Showing results (51-60 of 189) with videos related to
Sort By:
Page
of 19
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 18, 2012
The significance of defining preclinical or prodromal Parkinson's disease
C Warren Olanow, José A Obeso
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 22, 2011
Movement disorders 2011--the state of the journal
C Warren Olanow, Jose A Obeso
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 20, 2014
Impact factor for 2013
C Warren Olanow, Jose A Obeso
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 24, 2021
Parkinson's Disease Modification Through Abl Kinase Inhibition: An Opportunity
Milton H Werner, C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 11, 2008
Treatment of levodopa-induced motor complications
Fabrizio Stocchi, Michele Tagliati, C Warren Olanow
Annals of Neurology
|
July 25, 2006
Proteasome inhibitor-induced model of Parkinson's disease
Kevin St P McNaught, C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 11, 2014
Initiating levodopa therapy for Parkinson's disease
C Warren Olanow, Karl Kieburtz, Fabrizio Stocchi
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 9, 2018
Huntington's disease: Current and future therapeutic prospects
Karl Kieburtz, Ralf Reilmann, C Warren Olanow
Annals of Neurology
|
April 1, 2003
Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease
Kevin St P McNaught, C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 15, 2006
Ubiquitin-proteasome system and Parkinson's disease
C Warren Olanow, Kevin St P McNaught
Page
of 19